Riding the Digital Health Wave: The L.E.K. Digital Excellence Framework

Japan’s nationwide policy-level shifts are affecting medical device volume and pricing in an increasingly competitive market.

Companies need to understand Japan’s pricing system and anticipate and plan for potential challenges both in advance of and subsequent to launch. 

In this article, we describe some key drivers of asset value, as well as areas of alignment and divergence between parties on deal expectations.

This survey offers a glimpse into how a pandemic has changed the general population’s sentiment on healthcare and resulting behavior.

There is no doubt that COVID-19 has had a severe impact on the US healthcare ecosystem (as well as the rest of the economy) as providers have focused on…

Biopharmaceutical executives have engaged in extensive debates about the need for and effectiveness of value-based contracts (VBCs) ever since the…

Providers are on high alert due to the global impact of COVID-19. Current and potential future waves of infections, lockdowns and reopenings — and their…

Skyrocketing medical costs, clinical variation and outcomes that underindex those of other developed nations have risen to the forefront as key issues…

This report highlights how biopharma executives should adapt to the evolving biopharma landscape in both the nearer and longer term.

The following materials provide a snapshot of the unprecedented scope and speed of biopharma’s therapeutics research and development (R&D) response to…

The presence of artificial intelligence (AI) in life sciences is growing quickly as a result of multiple AI companies focusing on drug discovery and…

The Future of the Healthcare Industry: Q&A with L.E.K. Consulting's Evan Zeng